Theodore Tussing
Corporate Officer/Principal bij Stanford University School of Medicine
Profiel
Theodore Tussing founded IBRIX, Inc. in 2003, where he worked as Director.
Mr. Tussing also currently works at Stanford University School of Medicine, as Director-Stanford Corporate Partners.
Mr. Tussing also formerly worked at Cytograft Tissue Engineering, Inc., as Director and BioCardia, Inc., as Director.
Actieve functies van Theodore Tussing
| Bedrijven | Functie | Begin |
|---|---|---|
| Stanford University School of Medicine | Corporate Officer/Principal | - |
Eerdere bekende functies van Theodore Tussing
| Bedrijven | Functie | Einde |
|---|---|---|
BioCardia, Inc. /Old/
 BioCardia, Inc. /Old/ BiotechnologyHealth Technology BioCardia, Inc. is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The firm develops two comprehensive biotherapeutic products for cardiac arrest; CardiAMP and CardiALLO. CardiAMP is a bone marrow derived cell-based therapy for ischemic systolic heart failure patients who are not actively ischemic. CardiALLo is a allogeneic culture expanded mesenchymal bone marrow cells from a universal donor for use in multiple unrelated patients, entering Phase II development. Its other products also include Helix System and Morph Products. The company was founded in March 2002 and is headquartered in San Carlos, CA. | Directeur/Bestuurslid | - |
IBRIX, Inc.
 IBRIX, Inc. Packaged SoftwareTechnology Services IBRIX, Inc. provides data storage and software solutions. It offers products and services from design, transformation and management of corporate data centers. The company was founded by Steven Alan Orszag, Thomas Thekkethala, Theodore Tussing, and Eric Jackson on February 12, 2003 and is headquartered in Billerica, MA. | Oprichter | - |
Cytograft Tissue Engineering, Inc.
 Cytograft Tissue Engineering, Inc. Pharmaceuticals: MajorHealth Technology Cytograft Tissue Engineering, Inc. engages in the development of cardiovascular medicine. It offers novel cell-based therapies to repair and rebuild diseased tissues and organ without using synthetic biomaterials. The company was founded by Todd N. McAllister and Nicolas L'Heureux in 2000 and is headquartered in Novato, CA. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Cytograft Tissue Engineering, Inc.
Cytograft Tissue Engineering, Inc. Pharmaceuticals: MajorHealth Technology Cytograft Tissue Engineering, Inc. engages in the development of cardiovascular medicine. It offers novel cell-based therapies to repair and rebuild diseased tissues and organ without using synthetic biomaterials. The company was founded by Todd N. McAllister and Nicolas L'Heureux in 2000 and is headquartered in Novato, CA. | Health Technology |
BioCardia, Inc. /Old/
BioCardia, Inc. /Old/ BiotechnologyHealth Technology BioCardia, Inc. is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The firm develops two comprehensive biotherapeutic products for cardiac arrest; CardiAMP and CardiALLO. CardiAMP is a bone marrow derived cell-based therapy for ischemic systolic heart failure patients who are not actively ischemic. CardiALLo is a allogeneic culture expanded mesenchymal bone marrow cells from a universal donor for use in multiple unrelated patients, entering Phase II development. Its other products also include Helix System and Morph Products. The company was founded in March 2002 and is headquartered in San Carlos, CA. | Health Technology |
IBRIX, Inc.
IBRIX, Inc. Packaged SoftwareTechnology Services IBRIX, Inc. provides data storage and software solutions. It offers products and services from design, transformation and management of corporate data centers. The company was founded by Steven Alan Orszag, Thomas Thekkethala, Theodore Tussing, and Eric Jackson on February 12, 2003 and is headquartered in Billerica, MA. | Technology Services |